Machado Batista Sohn, Jeferson
Cardoso, Nathalie Carla
Raymundi, Ana Maria
Prickaerts, Jos
Stern, Cristina Aparecida Jark
Funding for this research was provided by:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/NUFFIC 2017/07)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (309111/2022-6)
Article History
Received: 1 August 2023
Accepted: 17 November 2023
First Online: 21 November 2023
Competing interests
: Jos Prickaerts has a proprietary interest in the PDE4 inhibitor roflumilast. The remaining authors have nothing to disclose.